Skip to main content
Clinical Trials/NCT01657877
NCT01657877
Completed
Phase 2

In Situ Study to Confirm the Anti-caries Potential of a 1.1365% w/w Sodium Monofluorophosphate (1500ppm F) Dentifrice

GlaxoSmithKline1 site in 1 country100 target enrollmentMay 2012

Overview

Phase
Phase 2
Intervention
Calcium sodium phosphosilicate
Conditions
Caries
Sponsor
GlaxoSmithKline
Enrollment
100
Locations
1
Primary Endpoint
Percentage (%) Change in Surface Microhardness (SMH) Following 21 Days of Twice Daily Treatment With the 1500 Ppm Fluoride + 5% CSP Dentifrice and With the 1500 Ppm Fluoride Dentifrice.
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

In situ study to compare treatment effect on enamel remineralization potential, measured by surface microhardness recovery (SMHR) and Enamel Fluoride Uptake (EFU). The study will explore the efficacy of an experimental sodium monofluorophosphate (SMFP) dentifrice containing calcium sodium phosphosilicate (CSP) in comparison to an experimental SMFP only dentifrice.

Registry
clinicaltrials.gov
Start Date
May 2012
End Date
June 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Wears a removable bilateral mandibular partial denture that has good stability and support, with sufficient room on each side in the posterior buccal flange area to accommodate two enamel specimens \[required dimensions 12 x 7 millimeters (mm)\].

Exclusion Criteria

  • Not provided

Arms & Interventions

CSP/SMFP Dentifrice

Dentifrice containing high fluoride content as SMFP and CSP

Intervention: Calcium sodium phosphosilicate

CSP/SMFP Dentifrice

Dentifrice containing high fluoride content as SMFP and CSP

Intervention: Sodium monoflurophosphate

SMFP Dentifrice Prototype 1

Dentifrice containing high fluoride content as SMFP and no CSP

Intervention: Sodium monoflurophosphate

SMFP Dentifrice Prototype 2

Dentifrice containing low fluoride content as SMFP and no CSP

Intervention: Sodium monoflurophosphate

CSP Dentifrice

Dentifrice containing CSP but no fluoride

Intervention: Calcium sodium phosphosilicate

Placebo Dentifrice

Dentifrice containing no CSP and no fluoride

Intervention: Placebo

Outcomes

Primary Outcomes

Percentage (%) Change in Surface Microhardness (SMH) Following 21 Days of Twice Daily Treatment With the 1500 Ppm Fluoride + 5% CSP Dentifrice and With the 1500 Ppm Fluoride Dentifrice.

Time Frame: Baseline to 21 days

Percent SMH recovery (SMHR) was calculated from hardness values of enamel specimens at baseline (B), after in-situ hardening (R) and after first demineralization challenge (D1) using formula: \[(D1-R)/ (D1-B)\]\*100. A greater percentage change in SMHR represents a better remineralisation and hence a better outcome.

Secondary Outcomes

  • Percentage (%) Change in SMH Following 21 Days of Twice Daily Treatment With 500 Ppm Fluoride as SMFP and 0 % CSP Dentifrice, 0 Ppm Fluoride and 0% CSP, and 0 Ppm Fluoride and 5 % CSP.(Baseline to 21 days)
  • Enamel Fluoride Uptake (EFU)(Baseline to 21 days)

Study Sites (1)

Loading locations...

Similar Trials